APA (7th ed.) Citation

VK, K., G, S., A, W., OC, R., A, P., V, I., . . . ML, A. (2014). SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker. Oncotarget, 5(5), 1212. https://doi.org/10.18632/oncotarget.1831

Chicago Style (17th ed.) Citation

VK, Kolukula, et al. "SLC25A1, or CIC, Is a Novel Transcriptional Target of Mutant P53 and a Negative Tumor Prognostic Marker." Oncotarget 5, no. 5 (2014): 1212. https://doi.org/10.18632/oncotarget.1831.

MLA (9th ed.) Citation

VK, Kolukula, et al. "SLC25A1, or CIC, Is a Novel Transcriptional Target of Mutant P53 and a Negative Tumor Prognostic Marker." Oncotarget, vol. 5, no. 5, 2014, p. 1212, https://doi.org/10.18632/oncotarget.1831.